Louisiana State University Shreveport is a public university in Shreveport, Louisiana. It is part of the Louisiana State University System.

During the past decade, Louisiana State University conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Louisiana State University" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "Agendia" with 1 trials sponsored, "Ansun Biopharma, Inc." with 1 trials sponsored and "Bausch Health Americas, Inc." with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Louisiana State University" #1 collaborator was "Eastern Cooperative Oncology Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Immune Tolerance Network (ITN)" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Louisiana State University" are "Lupus Nephritis" (2 trials), "Adenocarcinoma of the Colon" (1 trials), "Arteriovenous Fistula" (1 trials), "Autism" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Louisiana State University" in a lesser frequency.

Most popular intervention types in "Louisiana State University" are "Drug" (14 trials), "Biological" (3 trials), "Device" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Methylprednisolone" (2 trials), "Obinutuzumab" (2 trials), "Prednisone" (2 trials) and "Acetaminophen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Louisiana State University" are 15 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Louisiana State University". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Louisiana State University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Louisiana State University, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".